APA-viite

Pichumani, K., Ijare, O., Sharpe, M., Nguyen, L., Helekar, S., & Baskin, D. (2020). NIMG-48. USE OF MOBILE LIPIDS AS METABOLIC MARKERS FOR THE ASSESSMENT OF TREATMENT-INDUCED NECROSIS IN A RECURRENT GLIOBLASTOMA PATIENT TREATED WITH A NEW OSCILLATING MAGNETIC FIELD GENERATING DEVICE. Neuro Oncol.

Chicago-tyylinen lähdeviittaus

Pichumani, Kumar, Omkar Ijare, Martyn Sharpe, Lisa Nguyen, Santosh Helekar, ja David Baskin. "NIMG-48. USE OF MOBILE LIPIDS AS METABOLIC MARKERS FOR THE ASSESSMENT OF TREATMENT-INDUCED NECROSIS IN A RECURRENT GLIOBLASTOMA PATIENT TREATED WITH A NEW OSCILLATING MAGNETIC FIELD GENERATING DEVICE." Neuro Oncol 2020.

MLA-viite

Pichumani, Kumar, et al. "NIMG-48. USE OF MOBILE LIPIDS AS METABOLIC MARKERS FOR THE ASSESSMENT OF TREATMENT-INDUCED NECROSIS IN A RECURRENT GLIOBLASTOMA PATIENT TREATED WITH A NEW OSCILLATING MAGNETIC FIELD GENERATING DEVICE." Neuro Oncol 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.